Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 346 AL 360

Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial

McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L.

J Am Geriatr Soc. 2011 Aug;59(8):1393-402. doi: 10.1111/j.1532-5415.2011.03519.x. Epub 2011 Jul 28.

Fyn, a potential target for Alzheimer's disease

Yang K, Belrose J, Trepanier CH, Lei G, Jackson MF, MacDonald JF.

J Alzheimers Dis. 2011;27(2):243-52. doi: 10.3233/JAD-2011-110353.

FKBP immunophilins and Alzheimer's disease: a chaperoned affair

Cao W, Konsolaki M.

J Biosci. 2011 Aug;36(3):493-8. doi: 10.1007/s12038-011-9080-7.

Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study

Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW.

Lancet Neurol. 2011 Sep;10(9):785-96. doi: 10.1016/S1474-4422(11)70156-9. Epub 2011 Jul 27.

Comparison of polysomnographic variables and their relationship to cognitive impairment in patients with Alzheimer's disease and frontotemporal dementia

Kundermann B, Thum A, Rocamora R, Haag A, Krieg JC, Hemmeter U.

J Psychiatr Res. 2011 Dec;45(12):1585-92. doi: 10.1016/j.jpsychires.2011.07.008. Epub 2011 Jul 30.

[Profile of the informal carer associated with the clinical management of the Alzheimer's disease patient refractory to symptomatic treatment of the disease]

Molinuevo JL, Hernández B; Grupo de Trabajo del Estudio IMPACT.

Neurologia. 2011 Nov;26(9):518-27. doi: 10.1016/j.nrl.2011.05.011. Epub 2011 Jul 30.

Visual assessment of posterior atrophy development of a MRI rating scale

Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YA, Fox N, Barkhof F, Wattjes MP.

Eur Radiol. 2011 Dec;21(12):2618-25. doi: 10.1007/s00330-011-2205-4. Epub 2011 Jul 31.

Insights into Alzheimer disease pathogenesis from studies in transgenic animal models

Schaeffer EL, Figueiro M, Gattaz WF.

Clinics (Sao Paulo). 2011;66 Suppl 1(Suppl 1):45-54. doi: 10.1590/s1807-59322011001300006.

Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before

Mancuso C, Siciliano R, Barone E, Butterfield DA, Preziosi P.

Expert Opin Investig Drugs. 2011 Sep;20(9):1243-61. doi: 10.1517/13543784.2011.601740. Epub 2011 Aug 2.

Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria

Miklossy J.

J Neuroinflammation. 2011 Aug 4;8:90. doi: 10.1186/1742-2094-8-90.

The radical scavenger IAC (bis(1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl) decantionate) decreases mortality, enhances cognitive functions in water maze and reduces amyloid plaque burden in hAβPP transgenic mice

Puoliväli J, Nurmi A, Miettinen TK, Soleti A, Riccardino F, Kalesnykas G, Heikkinen T, Vartiainen N, Pussinen R, Tähtivaara L, Lehtimäki K, Yrjänheikki J, Canistro D, Sapone A, Spisni E, Paolini M.

J Alzheimers Dis. 2011;27(3):499-510. doi: 10.3233/JAD-2011-110881.

Pharmacological study on Alzheimer's drugs targeting calcium/calmodulin-dependent protein kinase II

Moriguchi S.

J Pharmacol Sci. 2011;117(1):6-11. doi: 10.1254/jphs.11r06cp. Epub 2011 Aug 6.

Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease

Cruchaga C, Nowotny P, Kauwe JS, Ridge PG, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, Goate AM; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Aug;68(8):1013-9. doi: 10.1001/archneurol.2011.155.

The dynamics of cortical and hippocampal atrophy in Alzheimer disease

Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, Schmansky NJ, Reuter M, Weiner MW, Buckner RL, Sperling RA, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Aug;68(8):1040-8. doi: 10.1001/archneurol.2011.167.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias